Empirical Antibiotic and Outcome in Community-onset Bacteremia

Identification of Gut Microbiome Biomarkers Associated to Acquisition of Enterobacteriae Highly Resistant to Third Generation Cephalosporines Following Ceftriaxone Treatment.

NCT03569917 ·Status: TERMINATED ·Phase: NA

Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients.

NCT02031588 ·Status: TERMINATED

Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments

NCT01703299 ·Status: COMPLETED

Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia

NCT06833593 ·Status: RECRUITING

Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases

NCT02127450 ·Status: COMPLETED

Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients

NCT02729116 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Selective Reporting for Antibiotic Susceptibility Testing and GPs' Prescribing of Broad-spectrum Antibiotics in Women With E. Coli UTIs

NCT06067386 ·Status: UNKNOWN ·Phase: NA

Bacterial Metallophores in the Diagnosis of Acute Pyelonephritis

NCT05674032 ·Status: UNKNOWN

Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae

NCT02420366 ·Status: COMPLETED

Exposure to Antibiotics and Incidence of Bacteraemia Caused by Resistant Bacteria

NCT04065750 ·Status: UNKNOWN

Prevalence of Enterobacteria With Decreased Susceptibility to Carbapenems in Eastern Inter- Region

NCT02803710 ·Status: UNKNOWN

Impact of Prescription Quality, Infection Control and Antimicrobial Stewardship on Gut Microbiota Domination by Healthcare-Associated Pathogens

NCT03765528 ·Status: UNKNOWN

Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae

NCT01138566 ·Status: UNKNOWN

Outcomes of Empiric Antibiotic Therapy Based on Hospital Antibiograms in Organ Transplant Recipients with Bacteraemia

NCT06874920 ·Status: ENROLLING_BY_INVITATION

Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs

NCT07093593 ·Status: NOT_YET_RECRUITING ·Phase: NA

Prevalence and Characterization of Diagnostic Error Among Patients With Bacteremia

NCT03577366 ·Status: COMPLETED

Impact of Prolonged Antibiotic Therapy on Commensal Microbial Community Gene Expression.

NCT05169255 ·Status: COMPLETED ·Phase: PHASE3

Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae

NCT02795949 ·Status: COMPLETED ·Phase: PHASE3

Burden of Antibiotic Resistance in Gram-Negative Infections in Dutch Hospitals

NCT02007343 ·Status: COMPLETED

Community-associated Highly-Resistant Enterobacterales

NCT03924934 ·Status: COMPLETED

Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread

NCT02666274 ·Status: UNKNOWN

Prevalence of Clinical Strains of Enterobacteria With Reduced Susceptibility to Carbapenems in the North-West Region of France

NCT02799225 ·Status: COMPLETED

Clinical Metagenomic of Post-traumatic Infections

NCT05770856 ·Status: COMPLETED

Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections

NCT00752219 ·Status: COMPLETED ·Phase: PHASE2

Resistance Profile of Escherichia Coli in Infections of Community Origin: The Importance of Antimicrobial Stewardship

NCT06305455 ·Status: NOT_YET_RECRUITING